✦ LIBER ✦

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: An 8-week, multicenter, randomized, open-label, dose-titration study in korean patients with hypercholesterolemia

✍ Scribed by Sang Hak Lee; Namsik Chung; Jun Kwan; Doo-Il Kim; Won Ho Kim; Chee Jeong Kim; Hyun Seung Kim; Si Hoon Park; Hong Seog Seo; Dong Gu Shin; Yung Woo Shin; Wan-Joo Shim; Tae Hoon Ahn; Kyeong Ho Yun; Myeong-Ho Yoon; Kwang-Soo Cha; Si-Wan Choi; Seong Wook Han; Min Su Hyon

Book ID: 116372062
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 627 KB
Volume: 29
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2007.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, open-label study to evalua

A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in korean patients with hypercholesterolemia

✍ Sungha Park; Hyun-Jae Kang; Se-Joong Rim; Jong-Won Ha; Byung-Hee Oh; Namsik Chun 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 913 KB

Efficacy and tolerability of two formula

Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: An 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial

✍ Sang-Hyun Kim; Woo-Young Chung; Joo-Hee Zo; Myung-A Kim; Hyuk-Jae Chang; Young-S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Efficacy and tolerability of atorvastati

Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: A 12-week, multicenter, double-blind, randomized, parallel-group study

✍ Michael H. Davidson; Michael W. Rooney; Joan Drucker; H. Eugene Griffin; Sonia O 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Efficacy and tolerability of intravenous

Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease

✍ Anatole Besarab; Moro O. Salifu; N. Martin Lunde; Vinod Bansal; Steven Fishbane; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 1017 KB

Efficacy and Tolerability of Pregabalin

Efficacy and Tolerability of Pregabalin Using a Flexible, Optimized Dose Schedule in Korean Patients With Peripheral Neuropathic Pain: A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

✍ Dong Eon Moon; Doo Ik Lee; Sang Chul Lee; Sun Ok Song; Duck Mi Yoon; Myung Ha Yo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 860 KB

Phase IV, 8-Week, Multicenter, Randomize

Phase IV, 8-Week, Multicenter, Randomized, Active Treatment–Controlled, Parallel Group, Efficacy, and Tolerability Study of High-Dose Candesartan Cilexetil Combined With Hydrochlorothiazide in Korean Adults With Stage II Hypertension

✍ Hae-Young Lee; Bum-Kee Hong; Wook Jin Chung; Byoung Kwon Lee; Seung Hwan Lee; Do 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 955 KB